CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Japan ,Italy ,Puerto Rico ,Milan ,Lombardia ,Japanese ,Silvio Danese ,Neil Gallagher ,Instagram ,Linkedin ,Twitter ,European Commission ,Exchange Commission ,University Vita ,Allergan ,European Medicines Agency ,Facebook ,Committee For Medicinal Products Human Use ,Medicinal Products ,Human Use ,San Raffaele Hospital ,University Vita Salute San Raffaele ,Important Safety Information ,Allergan Aesthetics ,Private Securities Litigation Reform Act ,Quarterly Reports ,Adapted Mayo ,Covid 19 ,Politics ,Science ,Health ,Pr Newswire ,